New insights in cryoglobulinemic vasculitis

被引:53
作者
Silva, Filipa [1 ]
Pinto, Claudemira [1 ]
Barbosa, Arsenio [1 ]
Borges, Tiago [2 ]
Dias, Carlos [1 ,3 ]
Almeida, Jorge [1 ]
机构
[1] Ctr Hosp Univ Sao Joao, Dept Internal Med, Porto, Portugal
[2] Hosp Privado Gaia, Dept Internal Med, Gaia, Portugal
[3] Ctr Hosp Univ Sao Joao, Autoimmune Dis Unit, Porto, Portugal
关键词
Cryoglobulinemia; Immunoglobulins; Vasculitis; Hematological disease; Hepatitis C virus; Rituximab; Antiviral therapy; HEPATITIS-C VIRUS; PRIMARY SJOGRENS-SYNDROME; MIXED CRYOGLOBULINEMIA; CLINICAL CHARACTERISTICS; I CRYOGLOBULINEMIA; INFECTION; PREVALENCE; MULTICENTER; AUTOIMMUNE; CLASSIFICATION;
D O I
10.1016/j.jaut.2019.102313
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Cryoglobulins are antibodies that precipitate at low temperatures and dissolve after rewarming. Cryoglobulinemia refers to the presence of circulating cryoglobulins and generally leads to a systemic inflammatory syndrome characterized by fatigue, arthralgia, purpura, ulcers, neuropathy and/or glomerulonephritis. The disease mainly involves small to medium-sized blood vessels and causes vasculitis due to cryoglobulin-containing immune complexes. Cryoglobulinemia is classified into three types (I, II and III) on the basis of immunoglobulin composition. Predisposing conditions include lymphoproliferative, autoimmune diseases and hepatitis C virus infection. The diagnosis of cryoglobulinemic syndrome is predominantly based on the presence of clinical features and laboratorial demonstration of serum cryoglobulins. The treatment strategy depends on the cause of cryoglobulinemia. For patients with chronic HCV infection, antiviral therapy is indicated. Immunosuppressive or immunomodulatory therapy, including steroids, plasmapheresis and cytotoxic agents, is reserved for organ-threatening manifestations. In this review, we discuss the main clinical presentations, diagnostic approach and treatment options.
引用
收藏
页数:7
相关论文
共 65 条
  • [1] Hematologic Manifestations and Predictors of Lymphoma Development in Primary Sjogren Syndrome Clinical and Pathophysiologic Aspects
    Baimpa, Evangelia
    Dahabreh, Issa J.
    Voulgarelis, Michael
    Moutsopoulos, Haralampos M.
    [J]. MEDICINE, 2009, 88 (05) : 284 - 293
  • [2] The clinical and morphologic spectrum of renal cryoglobulinemia
    Beddhu, S
    Bastacky, S
    Johnson, JP
    [J]. MEDICINE, 2002, 81 (05) : 398 - 409
  • [3] Belmonte M, 2013, ENFERMEDADES REUMATI
  • [4] Bonnet F, 2003, J RHEUMATOL, V30, P2005
  • [5] Predicting adverse outcomes in primary Sjogren's syndrome:: identification of prognostic factors
    Brito-Zeron, P.
    Ramos-Casals, M.
    Bove, A.
    Sentis, J.
    Font, J.
    [J]. RHEUMATOLOGY, 2007, 46 (08) : 1359 - 1362
  • [6] BROUET JC, 1974, AM J MED, V57, P775, DOI 10.1016/0002-9343(74)90852-3
  • [7] Bunchorntavakul C., 2013, J CLIN EXP HEPATOL, V8
  • [8] Hepatitis C-associated arthritis
    Buskila, D
    [J]. CURRENT OPINION IN RHEUMATOLOGY, 2000, 12 (04) : 295 - 299
  • [9] Clonal B cells in patients with hepatitis C virus-associated mixed cryoglobulinemia contain an expanded anergic CD21low B-cell subset
    Charles, Edgar D.
    Brunetti, Claudia
    Marukian, Svetlana
    Ritola, Kimberly D.
    Talal, Andrew H.
    Marks, Kristen
    Jacobson, Ira M.
    Rice, Charles M.
    Dustin, Lynn B.
    [J]. BLOOD, 2011, 117 (20) : 5425 - 5437
  • [10] Cicardi M, 2000, J VIRAL HEPATITIS, V7, P138